Neutrophil membrane biomimetic delivery system (Ptdser‐NM‐Lipo/Fer‐1) designed for targeting atherosclerosis therapy
IET Nanobiotechnology · 2023-06 · 17 (4) · 387-395
DOI: 10.1049/nbt2.12137 ↗Kurz gefasst
Fachartikel in der Zeitschrift IET Nanobiotechnology, online erschienen am 15.05.2023. Verfasst von Wei Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Neutrophils, Atherosclerosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yangzhou Science and Technology Project in Social Development.
Abstract (Originalsprache)
Atherosclerosis is a progressive inflammatory disease characterised by excessive lipid accumulation and inflammatory cell infiltration and is the basis of most cardiovascular diseases and peripheral arterial diseases. Therefore, an effectively targeted delivery system is urgently needed to deliver ferroptosis‐specific inhibitors to the site of arterial plaque and the inflammatory microenvironment. Inspired by the fact that neutrophils can be recruited to arterial plaques under the action of adhesion molecules and chemokines, the authors developed a neutrophil membrane hybrid liposome nano‐mimetic system (Ptdser‐NM‐Lipo/Fer‐1) that delivers Ferrostatin‐1 (Fer‐1) to the atherosclerotic plaque effectively, which is composed of Fer‐1‐loaded Ptdser‐modified liposomes core and neutrophils shell. Fer‐1 was released at the AS plaque site to remove reactive oxygen species (ROS) and improve the inflammatory microenvironment. In vitro ROS clearance experiments have shown that 50 μmol/ml Fer‐1 can significantly remove ROS produced by H 2 O 2 ‐induced MOVAS cells and Ptdser‐NM‐Lipo/Fer‐1 revealed a 3‐fold increase in the inhibition rate of ROS than free Fer‐1 in induced‐RAW264.7, demonstrating its superior ROS‐cleaning effect. Based on the interaction of adhesion molecules, such as vascular cell adhesion molecule 1, ICAM‐1, P‐selectin, E‐selectin, and chemokines released in the inflamed site, the aorta in NM‐Lipo‐treated mice displayed 1.3‐fold greater radiant efficiency than platelet membrane‐Lipo‐treated mice. Meanwhile, due to the modification of the Ptdser, the aorta in Ptdser‐NM‐Lipo/Fer‐1‐treated mice exhibited the highest fluorescence intensity, demonstrating its excellent targeting ability for atherosclerosis. Therefore, we present a specific formulation for the treatment of atherosclerosis with the potential for novel therapeutic uses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
- Department of Cardiology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
- Department of Pharmaceutics, State Key Laboratory of Nature Medicines, China Pharmaceutical University, Nanjing, China.
ORCID-Profile: Chang Liu
Förderung
- Yangzhou Science and Technology Project in Social Development
Zitieren
APA
Li, W., Liu, C., Wang, S., & Liu, N. (2023). Neutrophil membrane biomimetic delivery system (Ptdser‐NM‐Lipo/Fer‐1) designed for targeting atherosclerosis therapy. IET Nanobiotechnology, 17(4), 387-395. https://doi.org/10.1049/nbt2.12137
Vancouver
Li W, Liu C, Wang S, Liu N. Neutrophil membrane biomimetic delivery system (Ptdser‐NM‐Lipo/Fer‐1) designed for targeting atherosclerosis therapy. IET Nanobiotechnology. 2023;17(4):387-395. doi:10.1049/nbt2.12137
BibTeX
@article{Li2023,
author = {Li, Wei and Liu, Chang and Wang, Sichuan and Liu, Naifeng},
title = {Neutrophil membrane biomimetic delivery system (Ptdser‐NM‐Lipo/Fer‐1) designed for targeting atherosclerosis therapy},
journal = {IET Nanobiotechnology},
year = {2023},
volume = {17},
number = {4},
pages = {387--395},
doi = {10.1049/nbt2.12137}
}
EUVIMED